CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Emtricitabine/ rilpivirine/ tenofovir disoproxil fumarate

Last Updated: October 19, 2011
Result type: Reports
Project Number: S0256
Product Line: Common Drug Review

Generic Name: Emtricitabine/ rilpivirine/ tenofovir disoproxil fumarate

Brand Name: COMPLERA

Manufacturer: Gilead Science Canada Ltd.

Indications: HIV-1 infection in antiretroviral treatment- naïve adults

Submission Type: New

Project Status: Complete

Date Recommendation Issued: April 19, 2012

Recommendation Type: List